Basics |
Vera Therapeutics, Inc.
|
IPO Date: |
May 14, 2021 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$1.21B |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.77 | 3.48%
|
Avg Daily Range (30 D): |
$0.50 | 2.26%
|
Avg Daily Range (90 D): |
$0.75 | 2.85%
|
Institutional Daily Volume |
Avg Daily Volume: |
.41M |
Avg Daily Volume (30 D): |
.92M |
Avg Daily Volume (90 D): |
.86M |
Trade Size |
Avg Trade Size (Sh.): |
72 |
Avg Trade Size (Sh.) (30 D): |
68 |
Avg Trade Size (Sh.) (90 D): |
66 |
Institutional Trades |
Total Inst.Trades: |
1,396 |
Avg Inst. Trade: |
$2.28M |
Avg Inst. Trade (30 D): |
$2.45M |
Avg Inst. Trade (90 D): |
$2.04M |
Avg Inst. Trade Volume: |
.08M |
Avg Inst. Trades (Per Day): |
2 |
Market Closing Trades |
Avg Closing Trade: |
$3.31M |
Avg Closing Trade (30 D): |
$2.78M |
Avg Closing Trade (90 D): |
$2.7M |
Avg Closing Volume: |
111.07K |
|
|
|
|
Financials |
|
TTM |
Q1 2025 |
Q4 2024 |
Basic EPS
|
$-3
|
$-.81
|
$-.72
|
Diluted EPS
|
$-3
|
$-.81
|
$-.72
|
Revenue
|
$ M
|
$ M
|
$ M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -175.46M
|
$ -51.69M
|
$ -43.43M
|
Operating Income / Loss
|
$ -193.25M
|
$ -57.19M
|
$ -48.91M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ -14.02M
|
$ -37.56M
|
$ 65.39M
|
PE Ratio
|
|
|
|
|